You have no items in your shopping cart.
Report Store
The Report Store is a repository of research reports that are available for online purchase. Each provides an in-depth analysis of a single product or class of products in development within the pharmaceutical, biotechnology, device or diagnostics industries. The goal is to provide actionable insights that enable smart investment decisions around emerging product opportunities. Typically, the reports address:
- The scientific and medical rationale for use in the target indication
- The strength of available human efficacy and safety data, including the probability of late-phase trial success
- Regulatory (eg, FDA) concerns and their likely impact on approval and labeling
- Commercial opportunities, including an assessment of the competitive landscape and reimbursement issues.
| Items 1 to 10 of 80 total | Page: | Show per page |
Sort by
|
Biogen-Idec's and Knopp Biosciences' dexpramipexole for amyotrophic lateral sclerosis
Learn More
Raptor's RP 103 for nephropathic cystinosis - an orphan genetic disease
Tranzyme’s And Norgine’s Ulimorelin – Clinical, Regulatory And Commercial Prospects
Onyx's Carfilzomib
Micromet's blinatumomab: a first-in-class bispecific antibody
GTx's Capesaris - A novel medical castration method
Learn More
Lexicon's LX-4211 - a novel mechanism to treat diabetes
Learn More
Arqule's tivantinib for NSCLC
Learn More
Vical's Allovectin - Advancing immunotherapy for metastatic melanoma
Cubist's CXA-201 - A novel antibiotic for Gram-negative infections
Learn More
| Items 1 to 10 of 80 total | Page: | Show per page |
Sort by
|


